Maya Braun

Maya Braun

Auto-generated profile, based on publicly available information

Maya Braun

Department of Orthopaedic Surgery, Chaim Sheba Medical Center, Tel-Aviv University, Tel-Hashomer, Israel, Affiliated with the Faculty of Medicine of Tel-Aviv University, Ramat-Aviv, Tel-Aviv, Israel

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2019 in Genome Research
Verified
Journal Article
Open access
PDF file
DSDana Sherill-Rofe
Dana Sherill-Rofe
DRDolev Rahat
Dolev Rahat
SFSteven Findlay
Steven Findlay
AMAnna Mellul
Anna Mellul
IGIrene Guberman
Irene Guberman
YTYuval Tabach
Yuval Tabach
The homologous recombination repair (HRR) pathway repairs DNA double-strand breaks in an error-free manner. Mutations in HRR genes can result in increased mutation rate and genomic rearrangements, and are associated with numerous genetic disorders and cancer. Despite intensive research, the HRR pathway is not yet fully mapped. Phylogenetic profiling analysis, which detects functional linkage between genes using coevolution, is a powerful approach to identify factors in many pathways. Nevertheless, phylogenetic profiling has limited predictive power when analyzing pathways with complex evolutionary dynamics such as the HRR. To map novel HRR genes systematically, we developed clade phylogenetic profiling (CladePP). CladePP detects local coevolution across hundreds of genomes and points to the evolutionary scale (e.g., mammals, vertebrates, animals, plants) at which coevolution occurred. We found that multiscale coevolution analysis is significantly more biologically relevant and sensitive to detect gene function. By using CladePP, we identified dozens of unrecognized genes that coevolved with the HRR pathway, either globally across all eukaryotes or locally in different clades. We validated eight genes in functional biological assays to have a role in DNA repair at both the cellular and organismal levels. These genes are expected to play a role in the HRR pathway and might lead to a better understanding of missing heredity in HRR-associated cancers (e.g., heredity breast and ovarian cancer). Our platform presents an innovative approach to predict gene function, identify novel factors related to different diseases and pathways, and characterize gene evolution.

1 July 2020 in iScience
Verified
Journal Article
Open access
MMMaya Miller
Maya Miller
AMAnna Mellul
Anna Mellul
MBMaya Braun
Maya Braun
DSDana Sherill-Rofe
Dana Sherill-Rofe
ECEmiliano Cohen
Emiliano Cohen
YTYuval Tabach
Yuval Tabach
PhenolaTi is an advanced non-toxic anticancer chemotherapy; this inert bis(phenolato)bis(alkoxo) Ti(IV) complex demonstrates the intriguing combination of high and wide efficacy with no detected toxicity in animals. Here we unravel the cellular pathways involved in its mechanism of action by a first genome study on Ti(IV)-treated cells, using an attuned RNA sequencing-based available technology. First, phenolaTi induced apoptosis and cell-cycle arrest at the G2/M phase in MCF7 cells. Second, the transcriptome of the treated cells was analyzed, identifying alterations in pathways relating to protein translation, DNA damage, and mitochondrial eruption. Unlike for common metallodrugs, electrophoresis assay showed no inhibition of DNA polymerase activity. Reduced in vitro cytotoxicity with added endoplasmic reticulum (ER) stress inhibitor supported the ER as a putative cellular target. Altogether, this paper reveals a distinct ER-related mechanism by the Ti(IV) anticancer coordination complex, paving the way for wider applicability of related techniques in mechanistic analyses of metallodrugs.

1 April 2019 in Journal of Molecular Biology
Verified
Journal Article
Closed access
LQLena Qawasmi
Lena Qawasmi
MBMaya Braun
Maya Braun
IGIrene Guberman
Irene Guberman
ECEmiliano Cohen
Emiliano Cohen
LNLamis Naddaf
Lamis Naddaf
YTYuval Tabach
Yuval Tabach

15 April 2025 in Clinical Orthopaedics and Related Research
Verified
Journal Article
Closed access
DPDan Md Prat
Dan Md Prat
MBMaya Braun
Maya Braun
AGAdi Givon
Adi Givon
SGSharon Goldman
Sharon Goldman
EKEldad Md Katorza
Eldad Md Katorza
SSShachar Md Shapira
Shachar Md Shapira
Background: Lower extremity injuries are common in conflict-related trauma, with gunshot wounds (GSWs) causing localized damage and explosive trauma leading to extensive tissue injuries. Existing research lacks direct comparisons of injury severity and treatment outcomes between GSWs and explosive trauma in modern conflicts. This study clarifies these differences to improve triage strategies, surgical planning, and rehabilitation protocols. Questions/purposes: (1) How did GSWs and explosive trauma differ in terms of injury severity, including the proportion of patients in each group who experienced open fractures, neurovascular injuries, and amputations, during the Israel-Gaza conflict? (2) What was the comparative frequency and type of surgical intervention performed for GSWs versus explosive trauma in lower extremities? Methods: Between October 7, 2023, and December 31, 2023, a total of 1815 patients were entered into the Israel National Trauma Registry (INTR) as having been injured during the Israel-Gaza conflict. The INTR is a comprehensive national database that collects standardized injury and treatment information from all Level 1 and Level 2 trauma centers in Israel, ensuring high-quality, consistent reporting of war-related injuries. Of these, we considered patients with lower extremity injuries and ICD-9 E-codes E979 and E990-E999 (terror and war-related injuries) as potentially eligible. Based on this criterion, 1318 patients sustained extremity injuries, and 51% (674) met our inclusion criteria for this study. Among them, 53% (357 of 674) sustained GSWs and 47% (317) suffered explosive injuries. The groups did not differ in terms of mean ± SD ages (gunshot 28.5 ± 11.7 years, explosive 28.0 ± 11.4 years; p = 0.61). Most patients in both groups were men (gunshot 91%, explosive 95%; p = 0.09), with no between-group difference in terms of the proportion of patients who were men. Missing data were minimal in both groups, with complete data sets available for all primary outcomes. Comparisons were made between the two groups regarding the severity of injuries (such as open fractures and amputations), frequency and type of surgical interventions, and associated injuries (including those to the chest, abdomen, and face). Statistical analysis included chi-square tests for categorical variables and independent t-tests for continuous variables, with a significance threshold of p < 0.01 because of the large number of comparisons made. Results: GSWs resulted in a higher proportion of patients with open fractures (32% [115 of 357] versus 20% [64 of 317]; p = 0.001), particularly in the tibia and fibula (17% [62 of 357] versus 10% [33 of 317]; p = 0.01), whereas explosive injuries led to more amputations (10% [31 of 317] versus 3% [11 of 357]; p < 0.001); neurovascular injuries did not differ (p = 0.14 for nerve and p = 0.54 for vascular). A higher proportion of gunshot injuries were treated surgically (73% versus 59%; p < 0.001). Conclusion: Understanding the distinct injury patterns and outcomes of GSWs and explosive trauma is essential for improving patient care and resource allocation during conflicts. Given the high amputation rates in blast injuries, early rehabilitation and prosthetic support should be prioritized, while gunshot-related open fractures often call for expanded orthopaedic fixation and infection control. Trauma training should emphasize early surgery for GSWs and hemorrhage control for blast injuries. Future research should focus on long-term functional outcomes, protective gear efficacy, and improved battlefield evacuation strategies to enhance survivability and recovery. Level of Evidence: Level III, therapeutic study.

16 January 2024 in Circulation
Verified
Journal Article
Closed access
CCChristina Canavati
Christina Canavati
ASAhmad Siam
Ahmad Siam
SLSapir Labes
Sapir Labes
NTNirit Trabelsi
Nirit Trabelsi
EREshcar Regev
Eshcar Regev
DMDror Mevorach
Dror Mevorach

22 July 2025 in Clinical Orthopaedics and Related Research
Verified
Journal Article
Closed access
DPDan Md Prat
Dan Md Prat
ABAsaf Bloch
Asaf Bloch
MBMaya Braun
Maya Braun
AGAdi Givon
Adi Givon
SGSharon Goldman
Sharon Goldman
SSShachar Md Shapira
Shachar Md Shapira
Background: In 2023, the Israel-Gaza conflict escalated with the October 7, 2023, attack that has led to prolonged warfare. Upper extremity injuries, often resulting from explosions or gunshot wounds, have been a major cause of disability in this conflict. While previous studies have examined blast and ballistic trauma separately, there is a lack of direct, large-scale comparisons of their injury patterns, severity, and clinical management in a real-world conflict setting. It remains unclear whether gunshot wounds or explosion-related injuries result in more intensive surgical interventions or more frequent complications. Addressing these gaps is critical for improving trauma care and resource allocation in conflict zones. Questions/purposes: (1) What are the primary differences in injury patterns and severity, including the proportion of patients in each group who experienced open fractures, neurovascular injuries, and amputations between explosion-related and gunshot-related upper extremity injuries during the Israel-Gaza conflict? (2) How do the type and frequency of surgical interventions differ between patients with explosion-related and gunshot-related upper extremity injuries? Methods: Between October 7, 2023, and December 31, 2023, a total of 1815 patients were recorded in the Israel National Trauma Registry as having sustained injuries during the Israel-Gaza conflict. The Israel National Trauma Registry is a comprehensive national database that collects standardized injury and treatment information from all Level 1 and Level 2 trauma centers in Israel, ensuring high-quality and consistent reporting of war-related injuries. For this study, we identified patients with upper extremity injuries and ICD-9 E-codes E979 and E990-E999 (terror and war-related injuries) as potentially eligible. Based on these criteria, 695 patients sustained upper extremity injuries, and 86% (597) met our inclusion criteria. Among them, 49% (294 of 597) suffered gunshot wounds while 51% (303 of 597) sustained explosion-related injuries. The study population was divided into two groups: patients with gunshot wounds and those with explosive trauma. Both groups had similar mean ± SD ages, with gunshot-injured patients being slightly older overall (gunshot 30 ± 13 years, explosive 27 ± 9 years; p = 0.006). Most patients in both groups were men (gunshot 91%, explosive 98%; p < 0.001), with a higher proportion of women patients in the gunshot group. Missing data were minimal, and we had complete data sets for all primary outcomes. The two groups were compared based on injury severity (including fractures, nerve injuries, and amputations), frequency and type of surgical interventions, and associated injuries to other body regions. Because of the large number of comparisons made, p < 0.01 was considered statistically significant. Results: Patients with gunshot-related injuries typically had higher severity scores (Injury Severity Score 16 to 24 [severe injury] 18% [52 of 294] versus 10% [31 of 303] and Injury Severity Score 25 to 75 [critical injury] 12% [35 of 294] versus 10% [31 of 303]; p < 0.001) and a greater proportion of patients with nerve injuries (14% [41 of 294] versus 8% [23 of 303]; p = 0.001) and associated fractures (53% [157 of 294] versus 33% [99 of 303]; p < 0.001), whereas explosion-related injuries were characterized by more concomitant injuries in other body regions (79% [240 of 303] versus 64% [188 of 294]; p < 0.001). Gunshot injuries were more commonly treated surgically (79% [231 of 294] versus 55% [168 of 303]; p < 0.001) and resulted in longer hospital stays, with a higher proportion staying over 7 days (42% [124 of 294] versus 31% [93 of 303]; p < 0.001). Conclusion: Given the distinct injury patterns and treatment needs identified in this study, trauma surgeons should anticipate a higher likelihood of severe nerve injuries, fractures, and surgical interventions in patients with gunshot wounds, often calling for early and aggressive management, including nerve repair and reconstructive procedures. Military planners and medical logisticians should ensure that trauma teams in conflict zones have access to specialized surgical expertise, early rehabilitation programs, and sufficient resources for infection control and wound management. Additionally, training in nerve repair techniques and damage control orthopaedics should be emphasized for frontline surgeons. Future studies should focus on long-term functional outcomes of these injuries, exploring strategies to improve rehabilitation and limb salvage techniques in combat settings. Level of Evidence: Level III, therapeutic study.